Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Lignocaine (Pfizer)

Lignocaine (Pfizer) is a medicine containing the active ingredient(s) lidocaine (lignocaine). On this page you will find out more about Lignocaine (Pfizer), including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

The Therapeutic Goods Administration (TGA) has a recall notice on this product.

Lignocaine 50 mg/5 mL ampoules (Pfizer)

Recall Action Commencement Date: 11 August 2017 Expiry: Novemeber 2017

TGA Recall Reference: RC-2017-RN-01058-1

AUST R Number: 49296

Batch Number: A313

Reason: Pfizer Australia has been made aware that in one instance, Lignocaine 1% 50mg in 5mL ampoules were found inside of a box of Heparin 5000 IU in 5mL ampoules. Pfizer believes this to be an isolated case involving one Community Pharmacy in NSW.

Further information on this recall can be found at http://apps.tga.gov.au/PROD/SARA/arn-detail.aspx?k=RC-2017-RN-01058-1

Active ingredient in this medicine: lidocaine (lignocaine)

Pack size information

Please select the pack size from the options directly below to view information on the medicine.

Information for medicine and pack size:
Lignocaine (Pfizer) 1% (50 mg/5 mL) injection solution, 50 x 5 mL ampoules

Consumer Medicine Information leaflet:

This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.

Read leaflet

What this medicine is for

Lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. Treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.

Table of characteristics
Table of characteristics
Active ingredient
Visual appearance Clear colourless solution
Dosage Form Injection, solution
Route of administration Intravenous
Medicine schedule
5mL x 10: Prescription Only Medicine, or Prescription Animal Remedy
5mL x 5: Prescription Only Medicine, or Prescription Animal Remedy
5mL x 50: Prescription Only Medicine, or Prescription Animal Remedy

There is one type of pack available.

Pack type 1
Pack type 1
Type Ampoule
Storage temperature Store below 25 degrees Celsius
Storage conditions No information available
Life time 18 Months
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Need more information?

These trusted information partners have more on this topic.

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo
Feedback